Estimated net proceeds ~$535.6M
Company: Core Scientific
The claim, verbatim
Core Scientific estimates net proceeds of approximately $535.6 million, or approximately $608.7 million if the initial purchasers fully exercise their option.
Source (primary)
core-scientific 8-K exhibit (exhibit992pricingpressrele.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-10-24)Live source ↗
Quote: “Core Scientific estimates that the net proceeds from the offering will be approximately $535.6 million (or approximately $608.7 million if the initial purchasers fully exercise their option to purchase additional notes)”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms core-scientific 8-K exhibit (exhibit992pricingpressrele.htm)
Quote: “Core Scientific estimates that the net proceeds from the offering will be approximately $535.6 million (or approximately $608.7 million if the initial purchasers fully exercise their option to purchase additional notes)”